This course provides an overview of the hepatitis C virus (HCV), including the function of the liver, HCV infection, risk factors for HCV infection, incidence and prevalence, signs and symptoms, natural history and progression, acute and chronic infection, health consequences, and coinfection. It examines such modes of transmission as drug use, tattooing and body piercing, transfusions and transplantations, sexual transmission, mother-to-infant transmission, and occupational transmission. It reviews various affected populations. It reviews diagnosis and testing, who should be tested, why individuals should be tested, and diagnostic tools. The course examines various treatment options, such as interferon treatment. Finally, the course examines a variety of prevention issues, such as HCV vaccines and prevention messages.
Mim Landry, Senior Science Writer, Danya International; Dwight Clark, M.B.A., Public Health Analyst, D.C. Department of Public Health/The HIV/AIDS Administration; Kelly Munly, M.S., Research Associate and Project Director, Danya International; and Paula M. Jones, Freelance Writer.
This course is sponsored by the Central East Addiction Technology Transfer Center and was developed with funding from CSAT.
This activity has been approved by NAADAC, the Association of Addiction Professionals for up to 2 credit hours under the Danya Institute’s Provider Number 309.
Time: 2 hours
By the end of this course, you will experience:
- Increased understanding of major modes of HCV transmission
- Increased knowledge about populations most at risk for contracting hepatitis C
- Increased familiarity regarding the natural course of HCV infection and the health-related consequences
- Increased recognition of the signs and symptoms of hepatitis C
- Increased understanding about how hepatitis C infection is diagnosed and how the course of the disease is monitored
- Increased familiarity regarding the therapies used to treat hepatitis C
- Increased knowledge regarding strategies for preventing further spread of HCV